IFNG and gastric cancer: In this study, we found that circMAN1A2 is transported by GC-derived exosomes and then taken up by T cells, inhibiting immune activation and the secretion of effectors such as TNF-α and IFN-γ, thus suppressing antitumour immunity and promoting GC progression.